Leading pharmatech unifies quality processes
for greater efficiency, collaboration, and compliance
BARCELONA, Spain, Sept. 14, 2023 /PRNewswire/ -- Veeva Systems
(NYSE: VEEV) today announced that LTS LOHMANN Therapie-Systeme AG
("LTS"), a leading pharmaceutical technology company, is partnering
with Veeva MedTech to advance its quality operations. LTS will use
Veeva Vault QMS to improve process control and visibility, align
global production sites, and increase audit readiness.
"As we continue to grow, we need a modern, scalable, and
user-friendly quality management tool to harmonize and advance our
quality processes across the organization," said Dr. Heike Barnikow-Bock, corporate vice president
operations, quality projects and consulting, LTS. "With Veeva Vault
QMS, we will strengthen oversight and GxP compliance while aligning
with the quality requirements of our customers."
"Veeva's open collaboration and flexibility to meet our needs
make it the perfect partner," said Christian Langer, corporate senior vice
president of global quality at LTS. "The team's breadth of
experience and focus on execution made completing this project in
such a short amount of time possible."
With headquarters in Germany
and four sites in North America,
Europe, and Asia, LTS develops and manufactures drug
delivery systems, such as transdermal patches, oral thin films, and
wearable drug delivery devices. Vault QMS will help LTS manage and
track quality processes, such as deviations, complaints, lab
incidents, corrective and preventive actions, and change control.
By improving its quality management processes, LTS can provide
greater value to its partners and drive better patient outcomes,
which aligns with the LTS purpose: "We CARE. We CREATE. We
DELIVER."
"Veeva Vault QMS helps companies like LTS simplify quality
processes for better efficiency while ensuring ongoing inspection
readiness," said Patrik Brehm,
director of quality strategy for Veeva MedTech in Europe. "Veeva is proud to partner with the
team to help streamline its quality operations."
Veeva MedTech offers unified, connected cloud software solutions
to help deliver medical devices and diagnostics to patients in
need. It includes Veeva Vault products across research and
development and commercial to help speed the total product
development lifecycle for medtech companies.
Vault QMS is part of Vault Quality Suite, which brings together
quality systems and processes on a single cloud platform to enable
efficient quality management.
About Veeva Systems
Veeva is the global leader in cloud software for the life
sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 1,000 customers, ranging
from the world's largest biopharmaceutical companies to emerging
biotechs. As a Public Benefit Corporation, Veeva is committed to
balancing the interests of all stakeholders, including customers,
employees, shareholders, and the industries it serves. For more
information, visit veeva.com/eu.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding
Veeva's products and services and the
expected results or benefits from use of
our products and services. These statements are based on
our current expectations. Actual results could differ
materially from those provided in this release and we have no
obligation to update such statements. There are numerous
risks that have the potential to negatively impact
our results, including the risks and uncertainties disclosed
in our filing on Form 10-Q for the period ended July 31, 2023, which you can
find here (a summary of risks which may impact our
business can be found on pages 38 and 39), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/lts-advances-quality-oversight-with-veeva-vault-qms-301926604.html